Eyal Breitbart
Modi'in Makkabbim Re'ut, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Journal: Neuro-oncology
Published: December 18, 2019
MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
Journal: Clinical and experimental immunology
Published: August 28, 2019
Newly characterized motile sperm domain-containing protein 2 promotes human breast cancer metastasis.
Journal: International journal of cancer
Published: January 08, 2018
Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats.
Journal: Basic & clinical pharmacology & toxicology
Published: September 25, 2017
Identification of Motile Sperm Domain-Containing Protein 2 as Regulator of Human Monocyte Migration.
Identification of Motile Sperm Domain-Containing Protein 2 as Regulator of Human Monocyte Migration.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 27, 2016
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
Journal: Digestive diseases and sciences
Published: December 29, 2015
VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme.
Journal: Journal of neuro-oncology
Published: February 03, 2015
Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
Journal: Current pharmaceutical design
Published: August 31, 2014
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.
Journal: Clinical and experimental immunology
Published: September 21, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 17, 2013
Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.
Journal: Atherosclerosis
Published: January 10, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026